Тамар Перец

Отделение: Онкология
Должность: Онколог
Языки: Английский, Иврит
Принимает: только взрослых

Профессор Тамар Перец.

Образование

Родилась 10 сентября 1952-го года в г.Гданьск, Польша. В 1979 году получила степень д-ра медицины в Еврейском университете, Иерусалим.

Специализация

Лечение рака молочных желез.

Научные публикации

Tumor analysis of BRCA carriers reveals genomic similarities although separated by time
The Active Tumor Vaccination in Combination With CDK4/6 Inhibitor Treatment: A Case Report
The functional role of Nudt2 in human triple negative breast cancer
Short report: Plasma based biomarkers detect radiation induced brain injury in cancer patients treated for brain metastasis: A pilot study
Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells
In Response
A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy
Rapid Classification of Sarcomas Using Methylation Fingerprint: A Pilot Study
Preventing skin toxicities induced by EGFR inhibitors by topically blocking drug-receptor interactions
Cognitive Retraining and Functional Treatment (CRAFT) for adults with cancer related cognitive impairment: a preliminary efficacy study
Distinct breast cancer phenotypes in BRCA 1/2 carriers based on ER status
Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring Lung Well-Differentiated Neuroendocrine Tumors: A Brief Report
A universal cell-free DNA approach for response prediction to preoperative chemoradiation in rectal cancer
Loss of Heterozygosity of BRCA1/2 as a Predictive Marker for Talazoparib Response
PTX Treatment of Colon Cancer: Mode of Action Based on Tumor Marker and Cytokine Kinetics
Macrophages Upregulate Estrogen Receptor Expression in the Model of Obesity-Associated Breast Carcinoma
Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics
Breast Cancer with Low Recurrence Score on Oncotype DX©: Interplay Between Early Recurrence, Lobular Histology and BRCA Mutation
Potential Refinement of Recurrence Score by pSTAT3 Status
Predictors of quality of life among adults with self-reported cancer related cognitive impairment
Genetic anticipation of breast cancer among BRCA1/BRCA2 mutation carriers: A retrospective study
Common founder BRCA2 pathogenic variants and breast cancer characteristics in Ethiopian Jews
Liquid biopsy reveals collateral tissue damage in cancer
Thyroid Hormones and Morphological Features of Primary Breast Cancer
Effect of pentoxifylline on colon cancer patients treated with chemotherapy (Part I)
"High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis"
A novel founder MSH2 deletion in Ethiopian Jews is mainly associated with early-onset colorectal cancer
Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions
Author Correction: ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin
Elevated Free Triiodothyronine Is Associated With Increased Proliferative Activity in Triple-negative Breast Cancer
Author Correction: ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin
ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin
Clinical Characteristics and Prognosis of Gastric Cancer Patients with BRCA 1/2 Germline Mutations: Report of Ten Cases and a Literature Review
Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary Breast Cancer
Splicing Factor Transcript Abundance in Saliva as a Diagnostic Tool for Breast Cancer
Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants
Correction: Exclusive destruction of mitotic spindles in human cancer cells
Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients
SLAMF6​ deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint
Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma-A Retrospective Study
Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes
Regulation of Heparanase in Diabetes-Associated Pancreatic Carcinoma
Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified Genes
Homologous recombination in lung cancer, germline and somatic mutations, clinical and phenotype characterization
Heparanase Accelerates Obesity-Associated Breast Cancer Progression
The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients
Variable Features of Juvenile Polyposis Syndrome With Gastric Involvement Among Patients With a Large Genomic Deletion of BMPR1A
Life and death of circulating cell-free DNA
Lacosamide at therapeutic concentrations induces histone hyperacetylation in vitro
Combined Expression of Genetic Adjuvants Via mRNA Electroporation Exerts Multiple Immunostimulatory Effects on Antitumor T Cells
Показать ещё 42 статьи Скрыть статьи
Заболевания
Воспалительный рак молочной железы
Рак желудка
Рак пищевода
Болезнь Педжета молочной железы
Процедуры
Таргетная терапия
Остались вопросы?
Напишите нам и мы свяжемся с вами в течение ближайшего времени и ответим на все интересующие вопросы